Literature DB >> 12815197

Colocalization of Tie2, angiopoietin 2 and vascular endothelial growth factor in fibrovascular membrane from patients with retinopathy of prematurity.

Naoyasu Umeda1, Hiroaki Ozaki, Hideyuki Hayashi, Hiroko Miyajima-Uchida, Kenji Oshima.   

Abstract

PURPOSE: The tyrosine kinase receptor Tie2 and its ligands, the angiopoietins (Angs), play important roles in vascular integrity and neovascularization, modulating vascular endothelial growth factor (VEGF) activity. To elucidate the potential role of Angs and the Tie2 system in retinopathy of prematurity (ROP), we have investigated the expression of Angs, Tie2 and VEGF within fibroproliferative membranes in ROP.
METHODS: Fibroproliferative membranes were obtained from 38 cases with stage 5 ROP at the time of vitrectomy. Membranes were fixed in formalin and embedded in paraffin. Each specimen was serially sectioned for immunohistochemistry. Polyclonal antibodies specific for Ang1, Ang2, Tie2 and VEGF were used for immunostaining. Immunoreactivity for von Willebrand factor (factor VIII) was also assessed to confirm the identity of vascular endothelial cells.
RESULTS: Positive staining for Tie2 was observed in 23 of 38 specimens (60.5%). Tie2 was localized in vascularized regions of fibrovascular membranes and was co- expressed with VEGF and factor VIII. Ang2 stained positively in 18 of 38 (47.3%) serial sections where Tie2 was present, and was also co-expressed with VEGF and factor VIII. Ang1 was not generally observed in these specimens (3/38).
CONCLUSIONS: VEGF and Ang2-Tie2 interactions may play an important role in the pathogenesis of ROP. Copyright 2003 S. Karger AG, Basel

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12815197     DOI: 10.1159/000071173

Source DB:  PubMed          Journal:  Ophthalmic Res        ISSN: 0030-3747            Impact factor:   2.892


  9 in total

1.  Expression of hypoxia-inducible factor-1alpha and the protein products of its target genes in diabetic fibrovascular epiretinal membranes.

Authors:  Ahmed M Abu El-Asrar; Luc Missotten; Karel Geboes
Journal:  Br J Ophthalmol       Date:  2007-01-17       Impact factor: 4.638

2.  Serum prorenin levels and diabetic retinopathy in type 2 diabetes: new method to measure serum level of prorenin using antibody activating direct kinetic assay.

Authors:  H Yokota; F Mori; K Kai; T Nagaoka; N Izumi; A Takahashi; T Hikichi; A Yoshida; F Suzuki; Y Ishida
Journal:  Br J Ophthalmol       Date:  2005-07       Impact factor: 4.638

Review 3.  Genetic susceptibility to retinopathy of prematurity: the evidence from clinical and experimental animal studies.

Authors:  Gerd Holmström; Peter van Wijngaarden; Douglas J Coster; Keryn A Williams
Journal:  Br J Ophthalmol       Date:  2007-12       Impact factor: 4.638

4.  Targeting Neovascularization in Ischemic Retinopathy: Recent Advances.

Authors:  Mohamed Al-Shabrawey; Mohamed Elsherbiny; Julian Nussbaum; Amira Othman; Sylvia Megyerdi; Amany Tawfik
Journal:  Expert Rev Ophthalmol       Date:  2013-06

Review 5.  Role of the retinal vascular endothelial cell in ocular disease.

Authors:  Arpita S Bharadwaj; Binoy Appukuttan; Phillip A Wilmarth; Yuzhen Pan; Andrew J Stempel; Timothy J Chipps; Eric E Benedetti; David O Zamora; Dongseok Choi; Larry L David; Justine R Smith
Journal:  Prog Retin Eye Res       Date:  2012-09-11       Impact factor: 21.198

6.  Regression Rates Following the Treatment of Aggressive Posterior Retinopathy of Prematurity with Bevacizumab Versus Laser: 8-Year Retrospective Analysis.

Authors:  Simona D Nicoară; Anne C Ștefănuţ; Constanta Nascutzy; Gabriela C Zaharie; Laura E Toader; Tudor C Drugan
Journal:  Med Sci Monit       Date:  2016-04-10

7.  Identification of proteins associated with clinical and pathological features of proliferative diabetic retinopathy in vitreous and fibrovascular membranes.

Authors:  Ingeborg Klaassen; Ewout W de Vries; Ilse M C Vogels; Antoine H C van Kampen; Machteld I Bosscha; David H W Steel; Cornelis J F Van Noorden; Sarit Y Lesnik-Oberstein; Reinier O Schlingemann
Journal:  PLoS One       Date:  2017-11-02       Impact factor: 3.240

8.  Upregulated VEGF and Robo4 correlate with the reduction of miR-15a in the development of diabetic retinopathy.

Authors:  Qiaoyun Gong; Fuqiang Li; Jia'nan Xie; Guanfang Su
Journal:  Endocrine       Date:  2019-04-12       Impact factor: 3.633

9.  Analysis of circulating hem-endothelial marker RNA levels in preterm infants.

Authors:  Tzipora Strauss; Sally Metsuyanim; Itai Pessach; Irit Shuchan-Eisen; Jacob Kuint; Benjamin Dekel
Journal:  BMC Pediatr       Date:  2009-06-25       Impact factor: 2.125

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.